Cambridge Investment Research Advisors
CRDF icon

Cambridge Investment Research Advisors’s Cardiff Oncology CRDF Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-297
Closed -$7K – 2164
2017
Q4 		$7K Sell
297
-13
-4% -$576 ﹤0.01% 2104
2017
Q3 		$16K Hold
310
– – ﹤0.01% 1986
2017
Q2 		$28K Sell
310
-34
-10% -$2.19K ﹤0.01% 1902
2017
Q1 		$29K Buy
344
+68
+25% +$9.23K ﹤0.01% 1746
2016
Q4 		$42K Buy
276
+13
+5% +$3.04K ﹤0.01% 1630
2016
Q3 		$85K Sell
263
-14
-5% -$5.1K ﹤0.01% 1680
2016
Q2 		$90K Buy
+277
New +$95.4K ﹤0.01% 1489
2015
Q1 		– Sell
-3,046
Closed -$943K – 1421
2014
Q4 		$943K Sell
3,046
-1,037
-25% -$336K 0.03% 510
2014
Q3 		$1.35M Sell
4,083
-571
-12% -$171K 0.04% 422
2014
Q2 		$1.17M Sell
4,654
-177
-4% -$56.7K 0.04% 409
2014
Q1 		$1.99M Buy
4,831
+755
+19% +$327K 0.08% 260
2013
Q4 		$1.68M Buy
4,076
+368
+10% +$164K 0.07% 274
2013
Q3 		$1.92M Buy
3,708
+1,795
+94% +$1.02M 0.08% 228
2013
Q2 		$963K Buy
+1,913
New +$865K 0.05% 329

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cambridge Investment Research Advisors's CRDF Position: Q1 2018 in Review

Cambridge Investment Research Advisors sold out of Cardiff Oncology (CRDF) in Q1 2018, closing a stake of 297 shares — an estimated $7K sold.

Cambridge Investment Research Advisors first reported a position in CRDF in Q2 2013 and held it in 14 quarters. The position peaked at $1.99M in Q1 2014. 37 funds tracked by Wall St. Rank hold CRDF as of Q1 2018.

  • Cambridge Investment Research Advisors reported no remaining Cardiff Oncology position as of Q1 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 297 Cardiff Oncology shares in Q1 2018, an estimated $7K.
  • Cambridge Investment Research Advisors first reported a position in Cardiff Oncology in Q2 2013 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's Cardiff Oncology position peaked at $1.99M in Q1 2014.
  • 37 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2018, filed 9 May 2018.